drugset / Trial / NCT05584657

Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

NCT05584657

Phase 3 Completed 2229 enrolled Iterum Therapeutics, International Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Study 310 is a clinical study which compares the effectiveness of oral sulopenem versus oral amoxicillin/clavulanate for the treatment of adult women with uncomplicated urinary tract infection.

Timeline

Start
2022-10-18
Primary completion
2023-11-03
Completion
2023-11-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin/clavulanate Unknown Oral
Subject Probenecid Small molecule 500 mg Oral
Subject sulopenem etzadroxil Small molecule 500 mg Oral